These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2901554)

  • 21. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 22. Tissue plasminogen activator versus urokinase.
    Ebers GC
    Lancet; 1988 Oct; 2(8618):1028. PubMed ID: 2902476
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tissue plasminogen activator following unsuccessful resuscitation in fulminant lung embolism?].
    Buss J
    Dtsch Med Wochenschr; 1995 Feb; 120(6):196. PubMed ID: 7851293
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion.
    Shortell CK; Queiroz R; Johansson M; Waldman D; Illig KA; Ouriel K; Green RM
    J Vasc Surg; 2001 Nov; 34(5):854-9. PubMed ID: 11700486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work.
    Ouriel K; Kandarpa K
    J Endovasc Ther; 2004 Aug; 11(4):436-46. PubMed ID: 15298504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The treatment of cerebrovascular thrombosis and embolism with fibrinolytic agents].
    Araki G
    No To Shinkei; 1992 Sep; 44(9):771-7. PubMed ID: 1476806
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
    Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary embolism: which thrombolytic should be chosen?].
    Pacouret G; Augusseau-Richard MP; Dessenne X; Pagot O; Charbonnier B
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11 Suppl):1763-7. PubMed ID: 8815837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of Lysyl-plasminogen-urokinase sequential treatment in thrombolytic therapy].
    Brochier M; Planiol T; Griguer P; Raynaud P; Fauchier JP; Charbonnier B; Latour F; Pellois A
    Coeur Med Interne; 1977; 16(4):513-21. PubMed ID: 589966
    [No Abstract]   [Full Text] [Related]  

  • 31. [Injections of urokinase into the pulmonary artery for the treatment of acute pulmonary embolism--evaluation of 3 cases].
    Takahashi T; Ozasa K; Shibata T; Tanimura C; Uyama M; Nakagawa H; Inui T; Mineo T; Miyao K
    Kokyu To Junkan; 1983 Apr; 31(4):451-6. PubMed ID: 6346443
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thrombolytic therapy of pulmonary artery embolism in early pregnancy with recombinant tissue-type plasminogen activator].
    Seifried E; Gabelmann A; Ellbrück D; Schmidt A
    Geburtshilfe Frauenheilkd; 1991 Aug; 51(8):655-8. PubMed ID: 1657684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of severe pulmonary embolism by the in situ injection of urokinase].
    Giard A; Pauchant M
    Nouv Presse Med; 1978 Dec; 7(44):4050. PubMed ID: 733578
    [No Abstract]   [Full Text] [Related]  

  • 34. [Management for deep venous thrombosis].
    Ishimaru S
    Kokyu To Junkan; 1993 Dec; 41(12):1155-8. PubMed ID: 8284536
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental study on liquefaction of intracranial hematoma: usefulness of tissue-plasminogen activator (t-PA), a hematolytic agent, and its combination].
    Ebina K; Okabe S; Manabe H; Iwabuchi T
    No Shinkei Geka; 1990 Oct; 18(10):927-34. PubMed ID: 2122269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients.
    Kim HS; Preece SR; Black JH; Pham LD; Streiff MB
    J Vasc Surg; 2008 Feb; 47(2):388-94. PubMed ID: 18241762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inefficiency of high doses of urokinase in a massive pulmonary embolism. Possible role of an oral contraceptive].
    Grand A; Drouin B; Ferry M; Heulin T; Murger JF
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2391. PubMed ID: 673811
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombolytic effects of tissue-type and urokinase-type plasminogen activators in rabbits with experimental pulmonary thromboembolization.
    Rahman F
    Fukuoka Igaku Zasshi; 1990 Sep; 81(9):303-12. PubMed ID: 2125971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Coronary thrombolysis with urokinase and t-PA--comparison of intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):782-9. PubMed ID: 12436616
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of recurrent pulmonary thromboembolism with direct infusion of urokinase into the pulmonary artery].
    Umezawa S; Sugimoto K; Fujiwara H; Nobusawa S; Innami R; Nagaoka H; Taniguchi K
    Kokyu To Junkan; 1985 Jan; 33(1):101-5. PubMed ID: 3983473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.